{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:35:48Z","timestamp":1787952948869,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Public Health Service","award":["NS093716"],"award-info":[{"award-number":["NS093716"]}]},{"name":"Public Health Service","award":["AG032958"],"award-info":[{"award-number":["AG032958"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS092228"],"award-info":[{"award-number":["NS092228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.virol.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T01:38:12Z","timestamp":1530668292000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons"],"prefix":"10.1016","volume":"522","author":[{"given":"Christina N.","family":"Como","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Cohrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.06.013_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.virol.2018.06.013_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.06.013_bib3","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/JVI.00476-14","article-title":"Comparison of varicella-zoster virus RNA sequences in human neurons and fibroblasts","volume":"88","author":"Baird","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.06.013_bib4","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1128\/JVI.00594-15","article-title":"Interferon gamma prolongs survival of varicella-zoster virus-infected human neurons in vitro","volume":"89","author":"Baird","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.06.013_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2014.04.014","article-title":"Varicella zoster virus DNA does not accumulate in infected human neurons","volume":"458\u2013459","author":"Baird","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.06.013_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00109-008-0378-3","article-title":"IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells","volume":"86","author":"Bocker","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.virol.2018.06.013_bib7","first-page":"917","article-title":"Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era","volume":"33","author":"Cacciapaglia","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.virol.2018.06.013_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1023\/A:1021608724117","article-title":"Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells","volume":"27","author":"Dopp","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.virol.2018.06.013_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.virol.2018.06.013_bib10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/ard.2009.125658","article-title":"Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists","volume":"69","author":"Garcia-Doval","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.virol.2018.06.013_bib11","first-page":"17","article-title":"Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.virol.2018.06.013_bib12","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1212\/NXI.0000000000000216","article-title":"VZV in biopsy-positive and -negative giant cell arteritis: analysis of 100\u2009+ temporal arteries","volume":"3","author":"Gilden","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.virol.2018.06.013_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.410220315","article-title":"Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia","volume":"22","author":"Gilden","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.virol.2018.06.013_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/306478a0","article-title":"Varicella-zoster virus DNA in human sensory ganglia","volume":"306","author":"Gilden","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.06.013_bib15","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1128\/JVI.01020-10","article-title":"Characterization of the host immune response in human Ganglia after herpes zoster","volume":"84","author":"Gowrishankar","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.06.013_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G","article-title":"TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1","volume":"28","author":"Grell","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2018.06.013_bib17","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1128\/JVI.01506-13","article-title":"Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons","volume":"87","author":"Grose","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.06.013_bib18","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1016\/S0021-9258(18)63791-3","article-title":"Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha)","volume":"264","author":"Hohmann","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.06.013_bib19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium","volume":"99","author":"Irwin","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.virol.2018.06.013_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-3542(91)90065-Y","article-title":"Effects of tumor necrosis factor alpha on replication of varicella-zoster virus","volume":"15","author":"Ito","year":"1991","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.06.013_bib21","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1212\/NXI.0000000000000246","article-title":"Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy","volume":"3","author":"Jones","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.virol.2018.06.013_bib22","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.virol.2018.06.013_bib23","first-page":"77","article-title":"Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines","volume":"15","author":"Koenig","year":"2013","journal-title":"AIDS Rev."},{"key":"10.1016\/j.virol.2018.06.013_bib24","first-page":"1303","article-title":"Signaling pathways mediated by tumor necrosis factor alpha","volume":"15","author":"Leong","year":"2000","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.virol.2018.06.013_bib25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.06.013_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM199009063231002","article-title":"Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia","volume":"323","author":"Mahalingam","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2018.06.013_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2008.09.004","article-title":"Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment","volume":"44","author":"Martinez-Taboada","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.virol.2018.06.013_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflamm."},{"issue":"Pt 5","key":"10.1016\/j.virol.2018.06.013_bib29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1099\/0022-1317-66-5-1149","article-title":"125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data","volume":"66","author":"Merlin","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2018.06.013_bib30","doi-asserted-by":"crossref","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","article-title":"Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States","volume":"12","author":"Minassian","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.virol.2018.06.013_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jbspin.2015.07.009","article-title":"Monitoring of Epstein-Barr virus (EBV)\/cytomegalovirus (CMV)\/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis","volume":"83","author":"Mourgues","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.virol.2018.06.013_bib32","doi-asserted-by":"crossref","first-page":"e1005028","DOI":"10.1371\/journal.ppat.1005028","article-title":"Neuronal interferon signaling is required for protection against herpes simplex virus replication and pathogenesis","volume":"11","author":"Rosato","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.06.013_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/QCO.0000000000000175","article-title":"Acute encephalitis in the immunocompromised individual","volume":"28","author":"Saylor","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.virol.2018.06.013_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02145-15","article-title":"Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion","volume":"7","author":"Song","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.virol.2018.06.013_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2018.06.013_bib36","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1073\/pnas.88.20.9292","article-title":"The two different receptors for tumor necrosis factor mediate distinct cellular responses","volume":"88","author":"Tartaglia","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.06.013_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1348-0421.2000.tb02599.x","article-title":"IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella","volume":"44","author":"Torigoe","year":"2000","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virol.2018.06.013_bib38","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2018.06.013_bib39","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1523\/JNEUROSCI.22-08-03025.2002","article-title":"Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways","volume":"22","author":"Yang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.virol.2018.06.013_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mayocp.2015.09.015","article-title":"Risk of stroke and myocardial infarction after herpes zoster in older adults in a US community population","volume":"91","author":"Yawn","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.virol.2018.06.013_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13365-012-0142-x","article-title":"Varicella zoster virus infection of highly pure terminally differentiated human neurons","volume":"19","author":"Yu","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.virol.2018.06.013_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.1994.tb06618.x","article-title":"Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures","volume":"98","author":"Zhang","year":"1994","journal-title":"Clin. Exp. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218301909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218301909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:45:08Z","timestamp":1758588308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218301909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"alternative-id":["S0042682218301909"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.06.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}